Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +1.12% slumped 0.53% to $170.20 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.57% rising 0.09% to 32,832.54 and the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +1.54% falling 0.12% to 4,140.06. This was the stock's third consecutive day of losses. Johnson & Johnson closed $16.49 below its 52-week high ($186.69), which the company achieved on April 25th.
The stock underperformed when compared to some of its competitors Monday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +5.70% rose 1.29% to $330.00, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.10% rose 1.24% to $88.49, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.18% rose 0.61% to $49.57. Trading volume (4.6 M) remained 2.1 million below its 50-day average volume of 6.7 M.